These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22045035)

  • 1. Pathophysiological modeling of obsessive-compulsive disorder: challenges, and progress.
    Pittenger C
    Biol Psychiatry; 2011 Dec; 70(11):1002-3. PubMed ID: 22045035
    [No Abstract]   [Full Text] [Related]  

  • 2. OCD is associated with an altered association between sensorimotor gating and cortical and subcortical 5-HT1b receptor binding.
    Pittenger C; Adams TG; Gallezot JD; Crowley MJ; Nabulsi N; James Ropchan ; Gao H; Kichuk SA; Simpson R; Billingslea E; Hannestad J; Bloch M; Mayes L; Bhagwagar Z; Carson RE
    J Affect Disord; 2016 May; 196():87-96. PubMed ID: 26919057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphometric brain characterization of refractory obsessive-compulsive disorder: diffeomorphic anatomic registration using exponentiated Lie algebra.
    Tang W; Li B; Huang X; Jiang X; Li F; Wang L; Chen T; Wang J; Gong Q; Yang Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():126-31. PubMed ID: 23876787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 5-HT
    Tiger M; Varnäs K; Okubo Y; Lundberg J
    Psychopharmacology (Berl); 2018 May; 235(5):1317-1334. PubMed ID: 29546551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin 1B Receptors Regulate Prefrontal Function by Gating Callosal and Hippocampal Inputs.
    Kjaerby C; Athilingam J; Robinson SE; Iafrati J; Sohal VS
    Cell Rep; 2016 Dec; 17(11):2882-2890. PubMed ID: 27974203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zolmitriptan (a 5-HT1B/1D receptor agonist with central action) does not increase symptoms in obsessive compulsive disorder.
    Boshuisen ML; den Boer JA
    Psychopharmacology (Berl); 2000 Sep; 152(1):74-9. PubMed ID: 11041318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anatomy and function of the orbital frontal cortex, II: Function and relevance to obsessive-compulsive disorder.
    Zald DH; Kim SW
    J Neuropsychiatry Clin Neurosci; 1996; 8(3):249-61. PubMed ID: 8854295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. White matter alterations in male patients with obsessive-compulsive disorder.
    Ha TH; Kang DH; Park JS; Jang JH; Jung WH; Choi JS; Park JY; Jung MH; Choi CH; Lee JM; Ha K; Kwon JS
    Neuroreport; 2009 May; 20(7):735-9. PubMed ID: 19322117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroimaging in obsessive-compulsive disorder.
    Kwon JS; Jang JH; Choi JS; Kang DH
    Expert Rev Neurother; 2009 Feb; 9(2):255-69. PubMed ID: 19210199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetylcysteine blocks serotonin 1B agonist-induced OCD-related behavior in mice.
    Allen EM; Hughes EF; Anderson CJ; Woehrle NS
    Behav Neurosci; 2018 Aug; 132(4):258-268. PubMed ID: 29985009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamine abnormalities in the SAPAP3 knockout model of obsessive-compulsive disorder-related behaviour.
    Wood J; LaPalombara Z; Ahmari SE
    Philos Trans R Soc Lond B Biol Sci; 2018 Mar; 373(1742):. PubMed ID: 29352023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A.E. Bennett Research Award. Toward a neurodevelopmental model of of obsessive--compulsive disorder.
    Rosenberg DR; Keshavan MS
    Biol Psychiatry; 1998 May; 43(9):623-40. PubMed ID: 9582996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered resting state functional connectivity patterns of the anterior prefrontal cortex in obsessive-compulsive disorder.
    Li P; Li S; Dong Z; Luo J; Han H; Xiong H; Guo Z; Li Z
    Neuroreport; 2012 Aug; 23(11):681-6. PubMed ID: 22692554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin system genes and obsessive-compulsive trait dimensions in a population-based, pediatric sample: a genetic association study.
    Sinopoli VM; Erdman L; Burton CL; Park LS; Dupuis A; Shan J; Goodale T; Shaheen SM; Crosbie J; Schachar RJ; Arnold PD
    J Child Psychol Psychiatry; 2019 Dec; 60(12):1289-1299. PubMed ID: 31321769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late-life reactivation of obsessive-compulsive disorder associated with lesions in prefrontal-subcortical circuits.
    Salinas C; Dávila G; Berthier ML; Green C; Lara JP
    J Neuropsychiatry Clin Neurosci; 2009; 21(3):332-4. PubMed ID: 19776315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Obsessive-compulsive disorders and structural cerebral alterations. Description of 3 cases].
    Cardona X; Avila A
    Neurologia; 2000; 15(6):253-7. PubMed ID: 11002703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically effective OCD treatment prevents 5-HT1B receptor-induced repetitive behavior and striatal activation.
    Ho EV; Thompson SL; Katzka WR; Sharifi MF; Knowles JA; Dulawa SC
    Psychopharmacology (Berl); 2016 Jan; 233(1):57-70. PubMed ID: 26423528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for inhibitory deficits in the prefrontal cortex in schizophrenia.
    Radhu N; Garcia Dominguez L; Farzan F; Richter MA; Semeralul MO; Chen R; Fitzgerald PB; Daskalakis ZJ
    Brain; 2015 Feb; 138(Pt 2):483-97. PubMed ID: 25524710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased N-Acetylaspartate/creatine ratio in the medial prefrontal cortex among unmedicated obsessive-compulsive disorder patients.
    Fan Q; Tan L; You C; Wang J; Ross CA; Wang X; Zhang T; Li J; Chen K; Xiao Z
    Psychiatry Clin Neurosci; 2010 Oct; 64(5):483-90. PubMed ID: 20923427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortical asymmetries in unaffected siblings of patients with obsessive-compulsive disorder.
    Peng Z; Li G; Shi F; Shi C; Yang Q; Chan RC; Shen D
    Psychiatry Res; 2015 Dec; 234(3):346-51. PubMed ID: 26522981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.